A randomized controlled trial on the effect of hydroxychloroquine in mild Graves' orbitopathy (GO-HCQ): study protocol. [PDF]
Lin CH +9 more
europepmc +1 more source
Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]
Kim W +7 more
europepmc +1 more source
MMP14 as a central mediator of TGF-β1-induced extracellular matrix remodeling in graves' orbitopathy. [PDF]
Wang X +6 more
europepmc +1 more source
Statin Use and the Risk of Developing Graves' Orbitopathy in Patients With Graves' Disease: A Systematic Review and Meta-Analysis With Regional and Gender-Stratified Analyses. [PDF]
Kermaj M +4 more
europepmc +1 more source
AWARENESS OF THE EUROPEAN GROUP ON GRAVES' ORBITOPATHY (EUGOGO) GUIDELINES AND THEIR PRACTICAL USAGE IN CROATIA: AN EUGOGO PILOT STUDY. [PDF]
Juri-Mandić J +9 more
europepmc +1 more source
Tryptophan metabolites exert potential therapeutic activity in graves' orbitopathy by ameliorating orbital fibroblasts inflammation and proliferation. [PDF]
Yang W +7 more
europepmc +1 more source
Novel immunoinflammatory blood markers in Graves' orbitopathy: insights into activity and severity. [PDF]
Abounoori M +5 more
europepmc +1 more source
Unilateral Graves' Orbitopathy in a Patient with Marine-Lenhart Syndrome: A case report. [PDF]
Alfutaisi A +6 more
europepmc +1 more source
Elimination of oral foci of infection might lead to clinical improvement of Graves' orbitopathy. [PDF]
Sawicka-Gutaj N +6 more
europepmc +1 more source

